Neurocrine Biosciences Tech Stack

Biopharmaceutical company developing treatments for neurological, psychiatric, and endocrine disorders

Biotechnology Research San Diego, California 1,001–5,000 employees Founded 1992 Public Company

Neurocrine Biosciences is a public biopharmaceutical company with an FDA-approved portfolio spanning movement disorders, psychiatric conditions, and endocrine dysfunction, plus mid-to-late-phase pipeline programs. The hiring mix is heavily sales-skewed (257 of 445 active roles), with projects focused on market penetration and long-term care adoption — a signal that the company is in a commercial execution phase across psychiatric and movement disorder segments rather than early discovery.

Tech Stack 33 technologies

Core StackWorkday Power BI Salesforce Python Databricks SAS NetSuite Veeva CRM Veeva Vault CRM HPLC UPLC GCP Microsoft Office Outlook PowerPoint Excel Veeva SQL TMS PLM qPCR ddPCR Salesforce Marketing Cloud Workfront Coupa Agiloft LC-MS FloQast RT-qPCR CDISC+3 more

AdoptingCDISC

What Neurocrine Biosciences Is Building

◆Challenges

Territory-specific barriers to product success
Product adoption in long-term care
Clinical regulatory reimbursement barriers
Ensuring distribution network integrity
Product acceptance and growth
Balancing compliance and reimbursement
Budget constraints
Compliance with regulations
Extended order fulfillment timelines
Territory-specific opportunities

▲Active Projects

Penetrate psychiatric and movement disorder marketplace
Product adoption in long-term care settings
Drive product acceptance through education
Territory sales strategy
Sales force strategy execution
Clinical development program
Implement sales force strategies
Drive product acceptance in targeted accounts
Targeted education and strategic account management
Targeted strategies for psychiatric and neurological markets

Hiring Activity

Decelerating440 roles · 85 in 30d

Department

Sales

257

Research

Healthcare

Marketing

Data

Ops

Legal

Product

Seniority

Mid

239

Senior

Manager

Director

Intern

Principal

Junior

Notable leadership hires: Medical Director, Scientific Director, Brand Director, Scientific Director, Toxicologic Pathology, Chief of Staff

Company intelligence

Find more companies like Neurocrine Biosciences by tech stack, pain points and active projects

Get started free

About Neurocrine Biosciences

Founded in 1992, Neurocrine Biosciences develops and commercializes therapies for neurological, psychiatric, endocrine, and immunological disorders. The company maintains an approved treatment portfolio covering tardive dyskinesia, Huntington's disease chorea, congenital adrenal hyperplasia, endometriosis, and uterine fibroids, with several programs in clinical development. Headquartered in San Diego with 1,001–5,000 employees, the company operates across the United States, Switzerland, and the United Kingdom. The infrastructure stack reflects a regulated pharma operation: Veeva CRM and Vault for regulatory and commercial management, Workday for HR/finance, Salesforce and Marketing Cloud for sales and customer engagement, alongside scientific tools (HPLC, UPLC, qPCR, LC-MS) embedded in research and manufacturing workflows.

HeadquartersSan Diego, California

Company Size1,001–5,000 employees

Founded1992

Hiring MarketsUnited States, Switzerland, United Kingdom

Frequently Asked Questions

What is Neurocrine Biosciences' approved product portfolio?

The company markets FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis, and uterine fibroids. Additional programs are in mid-to-late-phase clinical development across core therapeutic areas.

Is Neurocrine Biosciences hiring sales roles?

Yes. Sales represents the largest hiring department with 257 open or recent roles out of 445 total active positions, reflecting commercial expansion across psychiatric and movement disorder markets.